Attitudes toward genetic testing in patients at risk for HNPCC/FAP and the German population

Genetic Testing

Volumn 6, Issue 4, 2002, Pages 273-280

  Berth, Hendrik ^a,b   Balck, Friedrich ^a   Dinkel, Andreas ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOMATOUS POLYP; ADULT; AGED; ARTICLE; ATTITUDE; CLINICAL ARTICLE; COLORECTAL CANCER; CULTURAL FACTOR; FAMILIAL CANCER; FEMALE; FINLAND; GENE TECHNOLOGY; GENETIC COUNSELING; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; GERMANY; HIGH RISK POPULATION; HUMAN; MALE; POPULATION; QUESTIONNAIRE;

ADENOMATOUS POLYPOSIS COLI; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; GENETIC SCREENING; GERMANY; HETEROZYGOTE; HUMANS; QUESTIONNAIRES;

EID: 0036912441     PISSN: 10906576     EISSN: None     Source Type: Journal    
DOI: 10.1089/10906570260471804     Document Type: Article

References (60)

1. Aktan-collan, K., Mecklin, J.-P., Jarvinen, H., Nyström-lahti, M., Peltomäki, P., Söderling, I., Uutela, A., De La Chapelle, A., and Kääriäinen, H. (2000). Predictive genetic testing for hereditary non-polyposis colorectal cancer: Uptake and long-term satisfaction. Int. J. Cancer 89, 44-50.
2. American Gastroenterological Association. (2001). American Gastroenterological Association Medical position statement: Hereditary colorectal cancer and genetic testing. Gastroenterology 121, 195-197.
3. Andrykowski, M.A., Munn, R.K., and Studts, J.L. (1996). Interest in learning of personal genetic risk for cancer: A general population survey. Prev. Med. 25, 527-536.
4. Aro, A.R., Hakonen, A., Hietala, M., Lonnqvist, J., Niemelä, P., Peltonen, L., and Aula, P. (1997). Acceptance of genetic testing in a general population: Age, education and gender differences. Patient Educ. Couns. 31, 41-49.
5. Balck, F., and Berth, H. (2002). Die Bedeutung der Familie beim Umgang mit hereditären Krebserkrankungen. Das Beispiel erblicher Darmkrebs. Kontext 34, 5-23.
6. Barns, I., Schibeci, R., Davison, A., and Shaw, R. (2000). "What do you think about genetic medicine?" Facilitating sociable public discourse on developments in the new genetics. Sci. Technol. Hum. Val. 25, 283-308.
7. Benkendorf, J.L., Reutenauer, J.E., Hughes, C.A., Eads, N., Willison, J., Powers, M., and Lerman, C. (1997). Patients' attitudes about autonomy and confidentiality in genetic testing for breast-ovarian cancer susceptibility. Am. J. Med. Genet. 73, 296-303.
8. Berth, H., Dinkel, A., and Balck, F. (2002a). Gentests für alle? Ergebnisse einer Repräsentativerhebung. Dtsch. Arztebl. 99, A1030-A1032.
9. Berth, H., Dinkel, A., and Balck, F. (2002b). Gesundheit durch Gentests? Einstellungen zu genetischen Untersuchungen in einer deutschlandrepräsentativen Stichprobe. Z. Gesundheitspsychol. 10, 97-107.
10. Beskow, L.M., Khoury, M.J., Baker, T.G., and Thrasher, J.F. (2001). The integration of genomics into public health research, policy and practice in the United States. Community Genet. 4, 2-11.
11. Biesecker, B.B., Ishibe, N., Hadley, D.W., Giambarresi, T.R., Kase, R.G., Lerman, C., and Struewing, J.P. (2000). Psychosocial factors predicting BRCA1/BRCA2 testing decisions in members of hereditary breast and ovarian cancer families. Am. J. Med. Genet. 93, 257-263.
12. Bluman, L.G., Rimer, B.K., Berry, D.A., Borstelmann, N., Iglehart, J.D., Regan, K., Schildkraut, J., and Winer, E.P. (1999). Attitudes, knowledge, and risk perceptions of women with breast and/or ovarian cancer considering testing for BRCA1 and BRCA2. J. Clin. Oncol. 17, 1040-1046.
13. Bosompra, K., Flynn, B.S., Ashikaga, T., Rairikar, C.J., Worden, J.K., and Solomon, L.J. (2000). Likelihood of undergoing genetic testing for cancer risk: A population-based study. Prev. Med. 30, 155-160.
14. Bosompra, K., Ashikaga, T., Flynn, B.S., Worden, J.K., and Solomon, L.J. (2001). Psychosocial factors associated with the public's willingness to pay for genetic testing for cancer risk: A structural equations model. Health Educ. Res. 16, 157-172.
15. Bundesärztekammer (1998). Richtlinien zur Diagnostik der genetischen Disposition für Krebserkrankungen. Dtsch. Arztebl. 95, A1396-A1403.
16. Cappelli, M., Surh, L., Humphreys, L., Verma, S., Logan, D., Hunter, A., and Allanson, J. (1999). Psychological and social determinants of women's decisions to undergo genetic counseling and testing for breast cancer. Clin. Genet. 55, 419-430.
17. Cappelli, M., Surh, L., Walker, M., Korneluk, Y., Humphreys, L., Verma, S., Hunter, A., Allanson, J., and Logan, D. (2001). Psychological and social predictors of decisions about genetic testing for breast cancer in high-risk women. Psychol. Health Med. 6, 321-333.
18. Chadwick, R., Ten Have, H., Hoedemaekers, R., Husted, J., Levitt, M., McGleenan, T., Shickle, D., and Wiesing, U. (2001). Euroscreen 2: Towards community policy on insurance, commercialization and public awareness. J. Med. Philos. 26, 263-272.
19. Codori, A.-M., Petersen, G.M., Miglioretti, D.L., Larkin, E.K., Bushey, M.T., Young, C., Brensinger, J.D., Johnson, K., Bacon, J.A., and Booker, S.V. (1999). Attitudes toward colon cancer gene testing: Factors predicting test uptake. Cancer Epidemiol. Biomark. Prev. 8, 345-351.
20. Coughlin, S.S., and Miller, D.S. (1999). Public health perspectives on testing for colorectal cancer susceptibility genes. Am. J. Prev. Med. 16, 99-104.
21. Esplen, M.J., Madlensky, L., Butler, K., McKinnon, W., Bapat, B., Wong, J., Aronson, M., and Gallinger, S. (2001). Motivations and psychosocial impact of genetic testing for HNPCC. Am. J. Med. Genet. 103, 9-15.
22. Faller, H. (1997). Genetische Testung bei familiärem Brustkrebs-Psychosoziale Forschung und zukünftige Strategien. Z. Med. Psychol. 6, 109-116.
23. Fraser, F.C. (2001). Resetting our educational sights: Unconstructing the public's dreams and nightmares of the genetic revolution. Am. J. Hum. Genet. 68, 828-830.
24. Hamann, H.A., Croyle, R.T., Venne, V.L., Baty, B.J., Smith, K.R., and Botkin, J.R. (2000). Attitudes toward the genetic testing of children among adults in a Utah-based kindred tested for a BRCA1 mutation. Am. J. Med. Genet. 92, 25-32.
25. Heiskanen, I., Luostarinen, T., and Järvinen, H.J. (2000). Impact of screening examinations on survival in familial adenomatous polyposis. Scand. J. Gastroenterol. 35, 1284-1287.
26. Henderson, B.J., and Maguire, B.T. (1998). Lay representations of genetic disease, and predictive testing. J. Health Psychol. 3, 233-241.
27. Henderson, B.J., and Maguire, B.T. (2000). Three lay mental models of disease inheritance. Soc. Sci. Med. 50, 293-301.
28. Hietala, M., Hakonen, A., Aro, A.R., Niemelä, P., Peltonen, L., and Aula, P. (1995). Attitudes towards genetic testing among the general population and relatives of patients with a severe genetic disease: A survey from Finland. Am. J. Hum. Genet. 56, 1493-1500.
29. Hofferbert, S., Worringen, U., Backe, J., Ruckert, E.M., White, K., Faller, H., Grimm, T., Caffier, H., Chang-Claude, J., and Weber, B.H. (2000). Simultaneous interdisciplinary counseling in German breast/ovarian cancer families: First experiences with patient perceptions, surveillance behavior and acceptance of genetic testing. Genet. Couns. 11, 127-146.
30. Jacobs, H., Latza, U., Vieregge, A., and Vieregge, P. (2001). Attitudes of young patients with Parkinson's disease towards possible presymptomatic and prenatal genetic testing. Genet. Couns. 12, 55-67.
31. Jallinoja, P., and Aro, A.R. (2000). Does knowledge make a difference? The association between knowledge about genes and attitudes toward gene tests. J. Health Commun. 5, 29-39.
32. Jallinoja, P., Hakonen, A., Aro, A.R., Niemelä, P., Hietala, M., Lonnqvist, J., Peltonen, L., and Aula, P. (1998). Attitudes towards genetic testing: Analysis of contradictions. Soc. Sci. Med. 46, 1367-1374.
33. Järvinen, H.J., Aarnio, M., Mustonen, H., Aktan-Collan, K., Aaltonen, L.A., Peltomäki, P., De La Chapelle, A., and MeCklin, J.-P. (2000). Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 118, 829-834.
34. Kaufert, P.A. (2000). Health policy and the new genetics. Soc. Sci. Med. 51, 821-829.
35. Keller, M. (2000). Gendiagnostik von hereditären Tumordispositionserkrankungen: Psychosoziale Aspekte. Z. Psychosom. Med. Psychother. 46, 80-97.
36. Khoury, M.J., Burke, W., and Thomson, E.J. (eds.) (2000). Genetics and Public Health in The 21st Century. Using Genetic Information To Improve Health and Prevent Disease. (Oxford University Press, New York).
37. Kreuz, F.R. (1996). Attitudes of German persons at risk for Huntington's disease toward predictive and prenatal testing. Genet. Couns. 7, 303-311.
38. Lerman, C., Schwartz, M.D., Lin, T.H., Hughes, C., Narod, S., and Lynch, H.T. (1997). The influence of psychological distress on use of genetic testing for cancer risk. J. Consult. Clin. Psychol. 65, 414-420.
39. Lerman, C., Hughes, C., Trock, B.J., Myers, R.E., Main, D., Bonney, A., Abbaszadegan, M.R., Harty, A.E., Franklin, B.A., Lynch, J.F., and Lynch, H.T. (1999). Genetic testing in families with hereditary nonpolyposis colon cancer. J. Am. Med. Assn. 281, 1618-1622.
40. Lichtenstein, P., Holm, N.V., Verkasalo, P.K., Iliadou, A., Kaprio, J., Koskenvuo, M., Pukkala, E., Xkytthe, Z., and Hemminki, K. (2000). Environmental and heritable factors in the causation of cancer. N. Engl. J. Med. 343, 78-85.
41. Matschinger, H., and Angermeyer, M.C. (1996). Zur Bedeutung von "weiß nicht"-Antworten bei der Messung von Einstellungen und Vorstellungen. Z. Diff. Diagnost. Psychol. 17, 18-39.
42. Michie, S., Drake, H., Bobrow, M., and Marteau, T. (1995). A comparison of public and professionals' attitudes towards genetic developments. Public Understand. Sci. 4, 243-253.
43. Neumann, P.J., Hammitt, J.K., Mueller, C., Fillit, H.M., Hill, J., Tetteh, N.A., and Kosik, K.S. (2001). Public attitudes about genetic testing for Alzheimer's disease. Health Aff. 20, 252-264.
44. O'Connor, B.V., and Cappelli, M. (1999). Health beliefs and the intent to use predictive genetic testing for cystic fibrosis carrier status. Psychol. Health Med. 4, 157-168.
45. Petersen, A. (2001). Biofantasies: Genetics and medicine in the print news media. Soc. Sci. Med. 52, 1255-1268.
46. Press, N.A., Yasui, Y., Reynolds, S., Durfy, S.J., and Burke, W. (2001). Women's interest in genetic testing for breast cancer susceptibility may be based on unrealistic expectations. Am. J. Med. Genet. 99, 99-110.
47. Ratzel, R. (2000). Grenzüberschreitender Gesundheitsmarkt innerhalb der EU, neue Chancen für Patienten und Leistungserbringer. Das deutsche Gesundheitswesen und der europäische Einigungsprozess. Urologe [B] 40, 50-52.
48. Regenauer, A. (2001). Kein Interesse am gläsernen patienten. Dtsch. Arztebl. 98, A593-A596.
49. Richards, M. (1996). Lay and professional knowledge of genetics and inheritance. Public Understand. Sci. 5, 217-230.
50. Risch, N. (2001). The genetic epidemiology of cancer; Interpreting family and twin studies and their implications for molecular genetic approaches. Cancer Epidemiol. Biomark. Prev. 10, 733-741.
51. Rosenstock, I.M. (1974). The Health Belief Model and preventive health behavior. Health Educ. Monogr. 2, 354-386.
52. Shaw, J.S., and Bassi, K.L. (2001). Lay attitudes toward genetic testing for susceptibility to inherited diseases. J. Health. Psychol. 6, 405-423.
53. Singer, E., Corning, A.D., and Antonucci, T. (1999). Attitudes toward genetic testing and fetal diagnosis, 1990-1996. J. Health Soc. Behav. 40, 429-445.
54. Smith, K.R., and Croyle, R.T. (1995). Attitudes toward genetic testing for colon cancer risk. Am. J. Public Health 85, 1435-1438.
55. Tambor, E.S., Rimer, B.K., and Strigo, T.S. (1997). Genetic testing for breast cancer susceptibility: Awareness and interest among women in the general population. Am. J. Med. Genet. 68, 43-49.
56. Terry, S.J., and Davidson, M.E. (2000). Empowering the public to be informed consumers of genetic technologies and services. Community Genet. 3, 148-150.
57. Turner, J., and Michael, M. (1996). What do we know about "don't knows"? Or, contexts of "ignorance". Soc. Sci. Inform. 35, 15-37.
58. Ulrich, C.M., Kristal, A.R., White, E., Hunt, J., Durfy, S.J., and Potter, J.D. (1998). Genetic testing for cancer risk: A population survey on attitudes and intention. Community Genet. 1, 213-222.
59. Van Herten, L.M., and Van De Water, H.P.A. (2000). Health policies on target? Review on health target setting in 18 European countries. Eur. J. Public Health 10(4 Suppl) 11-16.
60. Vernon, S.W., Gritz, E.R., Peterson, S.K., Perz, C.A., Marani, S., Amos, C.I., and Baile, W.F. (1999). Intention to learn results of genetic testing for hereditary colon cancer. Cancer Epidemiol. Biomark. Prev. 8, 353-360.